The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of tucatinib, trastuzumab, and capecitabine (TTC) following trastuzumab-deruxtecan (T-DXd) in HER2-positive metastatic breast cancer (MBC): Updated results and subgroup analyses from the UNICANCER multicenter retrospective cohort.
 
Jean-Sebastien Frenel
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca (Inst); Clovis Oncology (Inst); Daiichi Sankyo Europe GmbH (Inst); Eisai; Exact Sciences (Inst); Gilead Sciences; GlaxoSmithKline; Lilly; MSD Oncology (Inst); Novartis (Inst); Pfizer; Seagen
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; Gilead Sciences; Lilly; MSD Oncology; Novartis; Pfizer; seagen
 
Jean Zeghondy
Travel, Accommodations, Expenses - Novartis
 
Catherine Guerin
No Relationships to Disclose
 
Audrey Mailliez
Consulting or Advisory Role - SEAGEN
Travel, Accommodations, Expenses - Lilly; Menarini; MSD Oncology; Novartis
 
Elsa Volant
No Relationships to Disclose
 
Francois Poumeaud
No Relationships to Disclose
 
Anne Patsouris
Honoraria - Gilead Sciences (Inst)
Consulting or Advisory Role - AstraZeneca (Inst); Gilead Sciences (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Eisai; Eisai; NOVARTIS; NOVARTIS; Pfizer; Roche
 
Monica Arnedos
Honoraria - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; Menarini; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; Novartis; Pfizer
 
Caroline Bailleux
Stock and Other Ownership Interests - SigBio
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; AstraZeneca/Daiichi Sankyo; Lilly; MSD; Novartis; Seagen; Viatris
Travel, Accommodations, Expenses - Novartis
 
Fanny Le Du
Honoraria - Amgen; Daiichi Sankyo/Astra Zeneca; Lilly; Menarini; MSD Oncology; Novartis; Seagen
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Lilly; Novartis; Pfizer; Roche; Sandoz; Seagan
Research Funding - Daiichi Sankyo/Astra Zeneca
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Lilly; Novartis; Pfizer; Pierre Fabre; Roche; Seagan
 
Loik Galland
Honoraria - MSD
 
Alexandre de Nonneville
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Exact Sciences; Gilead Sciences; Lilly; Seagen
Speakers' Bureau - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Menarini; MSD Oncology; Novartis; Pfizer
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Gilead Sciences
 
Severine Guiu Lahaye
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - Novartis; Novartis
 
Barbara Pistilli
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/UCB Japan; Myriad Genetics; Novartis; Olema Oncology (Inst); PIERRE FABRE; Puma Biotechnology
Research Funding - AstraZeneca (Inst); DAIICHI-SANKYO (Inst); Gilead Sciences (Inst); Merus (Inst); Pfizer (Inst); Puma Biotechnology (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; MSD Oncology; Novartis; Pfizer; Pierre Fabre
 
Florence Dalenc
Consulting or Advisory Role - AstraZeneca (Inst); Daiichi Sankyo (Inst); Gilead Sciences (Inst); Novartis (Inst); Pfizer (Inst); Seagan (Inst)
Travel, Accommodations, Expenses - Gilead Sciences (Inst); Novartis (Inst)
 
Thomas Bachelot
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Lilly; Novartis; Pfizer; Seagen
Research Funding - AstraZeneca (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Novartis (Inst); Pfizer (Inst); SeaGen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Novartis; pfizer; Roche
 
Jean-Yves Pierga
Honoraria - Daiichi Sankyo/Astra Zeneca (Inst); Gilead Sciences (Inst); Novartis (Inst)
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo Europe GmbH; Eisai Europe (Inst); Exact Sciences; Gilead Sciences; Lilly; Menarini Group; MSD Oncology; MSD Oncology (Inst); Novartis; Pfizer; Roche/Genentech; Roche/Genentech (Inst); Seagen; Veracyte
Research Funding - Roche (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; Gilead Sciences; Pfizer
 
Louis Larrouquere
Consulting or Advisory Role - AstraZeneca (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Lilly (Inst); Novartis (Inst)
Research Funding - Seagen (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Novartis
 
Delphine Loirat
No Relationships to Disclose